Clinical Trial Details

A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment With or Without Bevacizumab VS Standard of Care After Second-line Platinum-based Doublet Chemotherapy in Participants With Platinum-sensitive Recurrent Ovarian Cancer (TroFuse-022/ENGOT-ov84/GOG-3103)

IRB Protocol Number
GOG 3103

Clinical Trial Categories

  • Ovarian Cancer
Contact
Clinical Trials at 910-715-2200

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.